AstraZeneca has added to its oncology pipeline by licensing a small-molecule KRAS inhibitor from Chinese biotech Usynova for $24 million upfront. The compound – called UA022 – targets the KRASG12D ...
From screw-in bulbs and colorful LED strips to table lamps and outdoor string lights, check out the top smart lighting we've tested for illuminating your space and setting the mood. I'm PCMag's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results